NCT04978285

Brief Summary

Primary aim - To investigate the relationship between postoperative anaemia and patient-centred outcomes after major abdominal surgery. Secondary aim - To determine whether a more liberal perioperative IV fluid strategy increases the risk of postoperative anaemia (haemodilution). Hypothesis: Adults with anaemia in the immediate postoperative period following major abdominal surgery have a poorer quality of recovery and higher risk of complications, leading to poor disability-free survival when compared with patients without postoperative anaemia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

July 16, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 27, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2021

Completed
Last Updated

July 13, 2022

Status Verified

July 1, 2021

Enrollment Period

4 months

First QC Date

July 16, 2021

Last Update Submit

July 11, 2022

Conditions

Keywords

anemiacomplicationshemoglobinironpatient-centered outcomesurgery

Outcome Measures

Primary Outcomes (1)

  • Persistent disability or death by 90 days

    Defined as a World Health Organization Disability Assessment Schedule 2.0 (WHODAS) score of at least 24 points (on the 48-point scale) at both 30 and 90 days postoperatively, reflecting a disability level of at least 25% and being the threshold point between "disabled" and "not disabled" as per WHO guidelines. Disability was assessed by the participant, but if unable then we used the proxy's report.

    90 days after surgery

Secondary Outcomes (12)

  • Death: all-cause mortality at 90 days, then up to 12 months after surgery

    1 year

  • A composite (pooled) and individual septic complications: sepsis, surgical site infection, anastomotic leak, and pneumonia

    30 days

  • Sepsis: using Centers for Disease Control and Prevention (CDC) with National Healthcare Safety Network (NHSN) criteria

    30 days

  • Surgical site infection

    30 days

  • Pneumonia

    30 days

  • +7 more secondary outcomes

Study Arms (2)

Postoperative anemia

All patients enrolled in the RELIEF trial in which a postoperative Day 1-3 hemoglobin concentration was measured. Anaemia will be defined according to the World Health Organisation definition (males Hb \<130 g/L, and female Hb \<120 g/L).

Other: Anemia

No postoperative anemia

All patients enrolled in the RELIEF trial in which a postoperative Day 1-3 hemoglobin concentration was measured. No anaemia will be defined according to the World Health Organisation definition (males Hb ≥130 g/L, and females Hb ≥120 g/L).

Other: Anemia

Interventions

AnemiaOTHER

Depends on Day 3 Hb result

Also known as: Observational
No postoperative anemiaPostoperative anemia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult, elective major abdominal surgery

You may qualify if:

  • Adults (≥18 years) undergoing elective major surgery and providing informed consent
  • All types of open or lap-assisted abdominal or pelvic surgery with an expected duration of at least 2 hours, and an expected hospital stay of at least 3 days
  • At increased risk of postoperative complications, as defined by any of the following criteria:
  • age ≥70 years
  • known or documented history of coronary artery disease
  • known or documented history of heart failure
  • diabetes currently treated with an oral hypoglycemic agent and/or insulin
  • preoperative serum creatinine \>200 micromol/L (\>2.8 mg/dl)
  • morbid obesity (BMI ≥35 kg/m2)
  • preoperative serum albumin \<30 g/L
  • anaerobic threshold (if done) \<12 mL/kg/min
  • or two or more of the following risk factors:
  • ASA 3 or 4
  • chronic respiratory disease
  • obesity (BMI 30-35 kg/m2)
  • +4 more criteria

You may not qualify if:

  • Urgent or time-critical surgery
  • ASA physical status 5 - such patients are not expected to survive with or without surgery, and their underlying illness is expected to have an overwhelming effect on outcome (irrespective of fluid therapy)
  • Chronic renal failure requiring dialysis
  • Pulmonary or cardiac surgery - different pathophysiology, and thoracic surgery typically have strict fluid restrictions
  • Liver resection - most units have strict fluid/CVP limits in place and won't allow randomisation
  • Minor or intermediate surgery, such as laparoscopic cholecystectomy, transurethral resection of the prostate, inguinal hernia repair, splenectomy, closure of colostomy - each of these are typically "minor" surgery with minimal IV fluid requirements, generally low rates of complications and mostly very good survival.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alfred Hospital

Melbourne, Victoria, 3004, Australia

Location

Related Publications (2)

  • Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D, Christophi C, Leslie K, McGuinness S, Parke R, Serpell J, Chan MTV, Painter T, McCluskey S, Minto G, Wallace S; Australian and New Zealand College of Anaesthetists Clinical Trials Network and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery. N Engl J Med. 2018 Jun 14;378(24):2263-2274. doi: 10.1056/NEJMoa1801601. Epub 2018 May 9.

    PMID: 29742967BACKGROUND
  • Myles PS, Richards T, Klein A, Wood EM, Wallace S, Shulman MA, Martin C, Bellomo R, Corcoran TB, Peyton PJ, Story DA, Leslie K, Forbes A; RELIEF Trial Investigators. Postoperative anaemia and patient-centred outcomes after major abdominal surgery: a retrospective cohort study. Br J Anaesth. 2022 Sep;129(3):346-354. doi: 10.1016/j.bja.2022.06.014. Epub 2022 Jul 15.

MeSH Terms

Conditions

Anemia

Interventions

Watchful Waiting

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Outcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services Administration

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2021

First Posted

July 27, 2021

Study Start

July 16, 2021

Primary Completion

October 31, 2021

Study Completion

November 30, 2021

Last Updated

July 13, 2022

Record last verified: 2021-07

Locations